914 related articles for article (PubMed ID: 26424433)
21. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
[TBL] [Abstract][Full Text] [Related]
22. Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year.
Collins BF; Spiekerman CF; Shaw MA; Ho LA; Hayes J; Spada CA; Stamato CM; Raghu G
Chest; 2017 Jul; 152(1):103-112. PubMed ID: 28300570
[TBL] [Abstract][Full Text] [Related]
23. Serum MMP-9, SP-D, and VEGF levels reflect the severity of connective tissue disease-associated interstitial lung diseases.
Lv C; Zhang Q; Tang P; Guo L; Ding Q
Adv Rheumatol; 2022 Oct; 62(1):37. PubMed ID: 36303230
[TBL] [Abstract][Full Text] [Related]
24. Plasma LTBP2 as a potential biomarker in differential diagnosis of connective tissue disease-associated interstitial lung disease and idiopathic pulmonary fibrosis: a pilot study.
Zou M; Hu X; Song W; Gao H; Wu C; Zheng W; Cheng Z
Clin Exp Med; 2023 Dec; 23(8):4809-4816. PubMed ID: 37864077
[TBL] [Abstract][Full Text] [Related]
25. Comparison of characteristics of connective tissue disease-associated interstitial lung diseases, undifferentiated connective tissue disease-associated interstitial lung diseases, and idiopathic pulmonary fibrosis in Chinese Han population: a retrospective study.
Pan L; Liu Y; Sun R; Fan M; Shi G
Clin Dev Immunol; 2013; 2013():121578. PubMed ID: 24171031
[TBL] [Abstract][Full Text] [Related]
26. KL-6 levels in the connective tissue disease population: typical values and potential confounders-a retrospective, real-world study.
Zhou A; Tang H; Peng W; Wang Y; Tang X; Yang H; Lu R; Pan P
Front Immunol; 2023; 14():1098602. PubMed ID: 37409133
[TBL] [Abstract][Full Text] [Related]
27. Comparison of disease progression and mortality of connective tissue disease-related interstitial lung disease and idiopathic interstitial pneumonia.
Kocheril SV; Appleton BE; Somers EC; Kazerooni EA; Flaherty KR; Martinez FJ; Gross BH; Crofford LJ
Arthritis Rheum; 2005 Aug; 53(4):549-57. PubMed ID: 16082627
[TBL] [Abstract][Full Text] [Related]
28. Serum B-cell activating factor and lung ultrasound B-lines in connective tissue disease related interstitial lung disease.
Wang Y; Xie X; Zheng S; Du G; Chen S; Zhang W; Zhuang J; Lin J; Hu S; Zheng K; Mikish A; Xu Z; Zhang G; Gargani L; Bruni C; Hoffmann-Vold AM; Matucci-Cerinic M; Furst DE
Front Med (Lausanne); 2022; 9():1066111. PubMed ID: 36590969
[TBL] [Abstract][Full Text] [Related]
29. [Surfactant proteins-A and D as important serum markers for interstitial lung disease in patients with polymyositis or dermatomyositis].
Chen F; Shu XM; Wang DX; Xie Y; Wang GC
Zhonghua Yi Xue Za Zhi; 2012 Aug; 92(31):2182-5. PubMed ID: 23158422
[TBL] [Abstract][Full Text] [Related]
30. Circulating lung biomarkers in idiopathic lung fibrosis and interstitial lung diseases associated with connective tissue diseases: Where do we stand?
Elhai M; Avouac J; Allanore Y
Semin Arthritis Rheum; 2020 Jun; 50(3):480-491. PubMed ID: 32089354
[TBL] [Abstract][Full Text] [Related]
31. 18F-FDG Uptake in Less Affected Lung Field Provides Prognostic Stratification in Patients with Interstitial Lung Disease.
Nobashi T; Kubo T; Nakamoto Y; Handa T; Koyasu S; Ishimori T; Mishima M; Togashi K
J Nucl Med; 2016 Dec; 57(12):1899-1904. PubMed ID: 27339874
[TBL] [Abstract][Full Text] [Related]
32. Human epididymis protein 4 is associated with severity and poor prognosis of connective tissue disease-associated interstitial lung disease with usual interstitial pneumonia pattern.
Meng K; Tian M; Gui X; Xie M; Gao Y; Shi S; Zhao T; Xiao Y; Cai H; Ding J
Int Immunopharmacol; 2022 Jul; 108():108704. PubMed ID: 35413677
[TBL] [Abstract][Full Text] [Related]
33. Serum KL-6 as predictive and prognostic marker of interstitial lung disease in childhood connective tissue diseases: a pilot study.
El-Beheidy R; Domouky AM; Zidan H; Amer YA
Reumatismo; 2021 Nov; 73(3):. PubMed ID: 34814656
[TBL] [Abstract][Full Text] [Related]
34. Role of serum B-cell-activating factor and interleukin-17 as biomarkers in the classification of interstitial pneumonia with autoimmune features.
Zhao L; Liu L; Liu Y; Zheng H; Jiang P
Open Life Sci; 2024; 19(1):20220814. PubMed ID: 38465342
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the Diagnostic Efficacies of Serological Markers KL-6, SP-A, SP-D, CCL2, and CXCL13 in Idiopathic Interstitial Pneumonia.
Xue M; Guo Z; Cai C; Sun B; Wang H
Respiration; 2019; 98(6):534-545. PubMed ID: 31665737
[TBL] [Abstract][Full Text] [Related]
36. Serum Rcn3 level is a potential diagnostic biomarker for connective tissue disease-associated interstitial lung disease and reflects the severity of pulmonary function.
Ding F; Yang L; Wang Y; Wang J; Ma Y; Jin J
BMC Pulm Med; 2023 Feb; 23(1):68. PubMed ID: 36800954
[TBL] [Abstract][Full Text] [Related]
37. Serum Krebs von den Lungen-6 level as a diagnostic biomarker for interstitial lung disease in Chinese patients.
Hu Y; Wang LS; Jin YP; Du SS; Du YK; He X; Weng D; Zhou Y; Li QH; Shen L; Zhang F; Su YL; Sun XL; Ding JJ; Zhang WH; Cai HR; Dai HP; Dai JH; Li HP
Clin Respir J; 2017 May; 11(3):337-345. PubMed ID: 26077281
[TBL] [Abstract][Full Text] [Related]
38. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases.
Cai M; Bonella F; He X; Sixt SU; Sarria R; Guzman J; Costabel U
Respir Med; 2013 Sep; 107(9):1444-52. PubMed ID: 23831213
[TBL] [Abstract][Full Text] [Related]
39. [The role of B cell activating factor in the differential diagnosis of usual interstitial pneumonia].
Zhao YY; Lian HJ; Li S; Fang CL; Huang H; Xu ZJ
Zhonghua Jie He He Hu Xi Za Zhi; 2018 Jul; 41(7):544-550. PubMed ID: 29996351
[No Abstract] [Full Text] [Related]
40. Lung ultrasound B-lines and serum KL-6 correlate with the severity of idiopathic inflammatory myositis-associated interstitial lung disease.
Wang Y; Chen S; Lin J; Xie X; Hu S; Lin Q; Zheng K; Du G; Huang X; Zhang G; Gargani L; Matucci-Cerinic M; Furst DE
Rheumatology (Oxford); 2020 Aug; 59(8):2024-2029. PubMed ID: 31794028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
